The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder-Reference-Cited by-同舟云学术

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder

Published:2014-05-23 Issue:5 Volume:9 Page:e98099
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tomita Tetsu,Yasui-Furukori Norio,Nakagami Taku,Tsuchimine Shoko,Ishioka Masamichi,Kaneda Ayako,Sugawara Norio,Kaneko Sunao

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Depressive disorders – is it time to endorse different pathophysiologies?;IA Antonijevic;Psychoneuroendocrinology,2006

2. van Praag HM (2008) Kraepelin, biological psychiatry, and beyond. Eur Arch Psychiatry Clin Neurosci (Suppl 2): 29–32.

3. Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA);F Lamers;J Clin Psychiatry,2010

4. The impact of parental borderline personality disorder on vulnerability to depression in children of affectively ill parents;JR Abela;J Pers Disord,2005

5. Variability in the 5-HT(2A) receptor gene is associated with seasonal pattern in major depression;B Arias;Mol Psychiatry,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic correlates of clinical response in a naturalistic sample of escitalopram-treated patients;Expert Review of Clinical Pharmacology;2024-02-05

2. Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach;Neurochemistry International;2024-02

3. Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial;Journal of Personalized Medicine;2021-11-12

4. Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors;Frontiers in Pharmacology;2021-10-01

5. Analysis Approaches to Identify Pharmacogenetic Associations With Pharmacodynamics;Clinical Pharmacology & Therapeutics;2021-06-28